<script src="/scripts/jquery.magnific-popup.min.js"></script>
  • Professor, Surgery, CWRU School of Medicine

Education & Training


1992, Vanderbilt University

Medical / Professional School(s)

1997, Keck Medical Center of USC (Keck Hospital of USC)


1998, General Surgery - Massachusetts General Hospital


2004, General Surgery - Massachusetts General Hospital


2005, Laparoscopic Surgery - Carolinas Medical Center

Research Fellowship

2002, Minimally Invasive Surgery - Cleveland Clinic


Gastrointestinal Surgery, Gastrointestional Cancer, Hernia Surgery, Laparoscopic and Minimally Invasive Surgery, Upper Gastrointestinal Cancer

Selected Publications

Inflammatory Bowel Disease in Children and Adolescents.
Rosen MJ, Dhawan A, Saeed SA

Designing a ventral hernia staging system.
Petro CC, O'Rourke CP, Posielski NM, Criss CN, Raigani S, Prabhu AS, Rosen MJ

IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.
Waddell A, Vallance JE, Moore PD, Hummel AT, Wu D, Shanmukhappa SK, Fei L, Washington MK, Minar P, Coburn LA, Nakae S, Wilson KT, Denson LA, Hogan SP, Rosen MJ

An improved approach to separating startle data from noise.
Grimsley CA, Longenecker RJ, Rosen MJ, Young JW, Grimsley JM, Galazyuk AV

Permissible Intraabdominal Hypertension following Complex Abdominal Wall Reconstruction.
Petro CC, Raigani S, Fayezizadeh M, Rowbottom JR, Klick JC, Prabhu AS, Novitsky YW, Rosen MJ

Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease--authors' reply.
Rosen MJ, Minar P, Vinks AA

Reply to comment to article: Posterior component separation with transversus abdominis release successfully addresses recurrent ventral hernias following anterior component separation. Bruce Tulloh, Andrew Charles de Beaux, DOI 10.1007/s10029-015-1391-4.
Pauli EM, Rosen MJ

Microbial diversity. Fine-scale diversity and extensive recombination in a quasisexual bacterial population occupying a broad niche.
Rosen MJ, Davison M, Bhaya D, Fisher DS

A Multidisciplinary Approach to Medical Weight Loss Prior to Complex Abdominal Wall Reconstruction: Is it Feasible?
Rosen MJ, Aydogdu K, Grafmiller K, Petro CC, Faiman GH, Prabhu A

Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis.
Rosen MJ, Minar P, Vinks AA

View All Publications

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

For calendar year 2013, Michael Rosen, MD disclosed the following Outside Relationships with Industry:

Davol - Consulting

LifeCell - Consulting